Company intelligence / Profile preview

Prodose

Saclay, Île-de-France, France

Ownership: Private
Development stage: Other

Overview

Prodose is a French healthcare company specializing in the preparation and distribution of radiopharmaceuticals for nuclear medicine. The company operates a network of radiopharmacies and utilizes automated dispensing technology to provide ready-to-use doses of radioactive tracers for nuclear medicine departments. Prodose's services are critical for diagnostic imaging procedures, such as PET and SPECT scans, primarily in the field of oncology. In 2018, the company was acquired by Curium, integrating its logistics and preparation expertise into Curium's global radiopharmaceutical platform.

Therapeutic areas: OncologyCardiovascularNeurology
Modalities: RadiopharmaceuticalSmall molecule
Industry: Medical Imaging

Partnerships

Curium

Beyond the preview

Go deeper on Prodose.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prodose.

Explore the full profile